Triple negative breast cancer (TNBC), defined by the lack of estrogen receptor (ER), progesterone receptor (PR) and HER2 gene amplification, represents approximately 15 to 20% of all breast cancer cases and is associated with the worst prognosis compared to other breast cancer subtypes [1-6]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.